SOURCE: DSM N.V.

September 23, 2010 04:15 ET

DSM announces management changes

HEERLEN, NETHERLANDS--(Marketwire - September 23, 2010) -



Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces the following management changes:

Mr. Anton Robek (1959), most recently President and CEO of DSM Melamine, will be appointed as Senior Vice President of DSM's Emerging Business Area (EBA) DSM Bio-based Products & Services with effect from 1 January 2011. In this role he will build on the success of this EBA, formerly named DSM White Biotechnology, and drive its further commercialization as outlined in the strategy: 'DSM in motion: driving focused growth'. Anton Robek will report to Mr. Rob van Leen, DSM's Chief Innovation Officer.

Mr. Volkert Claassen (1953), currently Vice President DSM White Biotechnology, has been appointed Vice President Strategy & Growth Options of the DSM Innovation Center and Vice President Strategy & Partnerships of DSM Bio- based Products & Services. Volkert Claassen has very successfully built the EBA DSM White Biotechnology into a launching platform for products and services in the areas of biofuels and biochemicals. His track record and extensive network in the biotechnology industry give DSM an excellent position to take this enlarged EBA to the next level.

DSM - the Life Sciences and Materials Sciences Company

Royal DSM N.V. creates solutions that nourish, protect and improve performance. Its end markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrical and electronics, life protection and housing. DSM manages its business with a focus on the triple bottom line of economic performance, environmental quality and social responsibility, which it pursues simultaneously and in parallel. DSM has annual net sales of about EUR8 billion and employs some 22,700 people worldwide. The company is headquartered in the Netherlands, with locations on five continents. DSM is listed on Euronext Amsterdam. More information:www.dsm.com

For more information:
 DSM Corporate Communications        DSM Investor Relations

 André van der Elsen                 Hans Vossen
 tel. +31 (0) 45 5787162             tel. +31 (0) 45 5782864
 fax +31 (0) 45 5740680              fax +31 (0) 10 4590275
 e-mailmedia.relations@dsm.com       e-mailinvestor.relations@dsm.com



[HUG#1446265]





Press release-pdf: http://hugin.info/130663/R/1446265/389251.pdf




This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: DSM N.V. via Thomson Reuters ONE

Contact Information